| Literature DB >> 32104687 |
Huan Gao1,2,3, Jianfang Xu2, Li Zhang2, Yingli Lu2, Binghong Gao3, Lianshi Feng2.
Abstract
This study examined the effects of 4 weeks of living high-training low and high (LHTLH) under moderate hypoxia on body weight, body composition, and metabolic risk markers of overweight and obese females. Nineteen healthy overweight or obese females participated in this study. Participants were assigned to the normoxic training group (NG) or the LHTLH group (HG). The NG participants lived and trained at sea level. The HG participants stayed for approximately 10 hours in a simulated 2300 m normobaric state of hypoxia for six days a week and trained for 2 hours 3 times a week under the same simulated hypoxia. The interventions lasted for 4 weeks. All groups underwent dietary restriction based on resting metabolic rate. The heart rate of the participants was monitored every ten minutes during exercise to ensure that the intensity was in the aerobic range. Compared with the preintervention values, body weight decreased significantly in both the NG and the HG (-8.81 ± 2.09% and -9.09 ± 1.15%, respectively). The fat mass of the arm, leg, trunk, and whole body showed significant reductions in both the NG and the HG, but no significant interaction effect was observed. The percentage of lean soft tissue mass loss in the total body weight loss tended to be lower in the HG (27.61% versus 15.94%, P=0.085). Between the NG and the HG, significant interaction effects of serum total cholesterol (-12.66 ± 9.09% versus -0.05 ± 13.36%,) and apolipoprotein A1 (-13.66 ± 3.61% versus -5.32 ± 11.07%, P=0.042) were observed. A slight increase in serum high-density lipoprotein cholesterol (HDL-C) was observed in the HG (1.12 ± 12.34%) but a decrease was observed in the NG (-11.36 ± 18.91%). The interaction effect of HDL-C between NG and HG exhibited a significant trend (P=0.055). No added effects on serum triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), or APO-B were observed after 4 weeks of LHTLH. In conclusion, 4 weeks of LHTLH combined with dietary restriction could effectively reduce the body weight and body fat mass of overweight and obese females. Compared with training and sleeping under normoxia, no additive benefit of LHTLH on the loss of body weight and body fat mass was exhibited. However, LHTLH may help to relieve the loss of lean soft tissue mass and serum HDL-C.Entities:
Year: 2020 PMID: 32104687 PMCID: PMC7036094 DOI: 10.1155/2020/3279710
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Subject characteristics.
| NG | HG | |
|---|---|---|
| Subjects, | 9 | 10 |
| Age, years | 16.61 ± 1.96 | 19.30 ± 1.92 |
| BMI (kg/m2) | 28.88 ± 4.08 | 27.97 ± 3.58 |
The daily composition of the training load.
| Physical activities | Duration (min/d) | Intensity |
|---|---|---|
| Walking or brisk walking | 120 | 20–40% HRR velocity<6 km/h |
| Jogging | 40 | 20–30% HRR velocity <6 km/h |
| Swimming or cycling | 40 | 30–40% HRR |
| Table tennis | 40 | 20–40% HRR |
| Badminton | 40 | 20–40% HRR |
| Aerobic dance | 30 | 20–40% HRR |
Figure 1Effect of normoxic and hypoxic exercises on body weight. Data are presented as the mean ± SD. NG, normoxic group. HG, LHTLH group. P < 0.05, pre versus post.
Figure 2Weekly loss of body weight during normoxic and hypoxic exercise interventions. Data are presented as the mean ± SD. NG, normoxic group. HG, LHTLH group. W1–W4 refers to the 1st week to the 4th week.
Changes in body FM and LSM before and after 4 weeks of the intervention.
| Variable | Pre | Post |
|
|
|---|---|---|---|---|
| Arm FM, kg | ||||
| NG | 3.85 ± 1.14 | 3.28 ± 0.98$ | 0.352 | 0.051 |
| HG | 3.34 ± 0.82 | 2.88 ± 0.78$ | ||
| Leg FM, kg | ||||
| NG | 11.56 ± 2.76 | 10.16 ± 2.50$ | 0.092 | 0.158 |
| HG | 10.83 ± 2.49 | 9.12 ± 2.31$ | ||
| Trunk FM, kg | ||||
| NG | 17.86 ± 3.86 | 15.59 ± 3.30$ | 0.903 | 0.001 |
| HG | 15.66 ± 3.58 | 13.45 ± 3.35$ | ||
| Total FM, kg | ||||
| NG | 34.27 ± 7.12 | 29.98 ± 6.19$ | 0.771 | 0.005 |
| HG | 30.80 ± 6.31 | 26.35 ± 5.76$ | ||
| Arm LSM, kg | ||||
| NG | 4.23 ± 0.82 | 4.13 ± 0.74$ | 0.139 | 0.124 |
| HG | 3.73 ± 0.87 | 3.71 ± 0.73 | ||
| Leg LSM, kg | ||||
| NG | 15.05 ± 1.83 | 14.60 ± 1.97$ | 0.659 | 0.112 |
| HG | 14.13 ± 2.65 | 13.77 ± 2.38$ | ||
| Trunk LSM, kg | ||||
| NG | 19.84 ± 2.87 | 18.46 ± 2.40$ | 0.108 | 0.145 |
| HG | 18.01 ± 3.17 | 17.31 ± 3.20$ | ||
| Total LSM, kg | ||||
| NG | 42.57 ± 5.21 | 40.53 ± 4.86$ | 0.111 | 0.142 |
| HG | 39.22 ± 6.88 | 38.07 ± 6.51$ | ||
Pre, preintervention. Post, postintervention. $P < 0.05, pre versus post. NG: normoxic training group; HG: hypoxic training group; FM: fat mass; LSM: lean soft tissue mass.
Figure 3The ratio of the total FM loss (FML) and total LSM loss (LSML) to body weight loss. FML: fat mass loss. LSML: lean soft tissue mass loss. Data are presented as the mean ± SD.
Changes in the serum lipid profile after 4 weeks of the intervention.
| Variable | Pre | Post |
|
|
|---|---|---|---|---|
| FFA, mmol/L | ||||
| NG | 0.46 ± 0.11 | 0.79 ± 0.30$ | 0.206 | 0.098 |
| HG | 0.55 ± 0.20 | 1.05 ± 0.26$ | ||
| TGs, mmol/L | ||||
| NG | 1.05 ± 0.33 | 0.85 ± 0.18 | 0.554 | 0.021 |
| HG | 0.97 ± 0.30 | 0.85 ± 0.13 | ||
| TC, mmol/L | ||||
| NG | 4.49 ± 0.79 | 3.87 ± 0.43$ | 0.040 | 0.225 |
| HG | 4.37 ± 1.16 | 4.32 ± 0.99 | ||
| LDL-C, mmol/L | ||||
| NG | 2.50 ± 0.75 | 2.34 ± 0.34 | 0.545 | 0.022 |
| HG | 2.50 ± 0.93 | 2.52 ± 0.75 | ||
| HDL-C, mmol/L | ||||
| NG | 1.29 ± 0.22 | 1.11 ± 0.19& | 0.055 | 0.200 |
| HG | 1.27 ± 0.20 | 1.30 ± 0.33 | ||
| LDL-C/HDL-C | ||||
| NG | 1.96 ± 0.53 | 2.16 ± 0.50 | 0.305 | 0.062 |
| HG | 2.04 ± 0.98 | 2.04 ± 0.82 | ||
| APO-A1, g/L | ||||
| NG | 1.16 ± 0.16 | 1.00 ± 0.13$ | 0.042 | 0.221 |
| HG | 1.23 ± 0.14 | 1.17 ± 0.23 | ||
| APO-B, g/L | ||||
| NG | 0.72 ± 0.16 | 0.67 ± 0.10 | 0.203 | 0.094 |
| HG | 0.70 ± 0.26 | 0.71 ± 0.19 | ||
| APO-A1/APO-B | ||||
| NG | 1.69 ± 0.42 | 1.54 ± 0.38$ | 0.566 | 0.020 |
| HG | 1.90 ± 0.50 | 1.71 ± 0.43$ | ||
Pre, preintervention. Post, postintervention. $P < 0.05; &0.05 < P < 0.1, pre versus post. NG: normoxic group; HG: hypoxic group; FFA: free fatty acid; TC: total cholesterol; TGs: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; APO-A1 and APO-B: apolipoprotein A1 and apolipoprotein B.